SomaLogic SLGC Stock
SomaLogic Price Chart
SomaLogic SLGC Financial and Trading Overview
| SomaLogic stock price | 2.1 USD |
| Previous Close | 2.45 USD |
| Open | 2.5 USD |
| Bid | 0 USD x 3200 |
| Ask | 0 USD x 3000 |
| Day's Range | 2.41 - 2.5 USD |
| 52 Week Range | 1.98 - 5.6 USD |
| Volume | 641.42K USD |
| Avg. Volume | 1.07M USD |
| Market Cap | 462.34M USD |
| Beta (5Y Monthly) | 1.911592 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.63 USD |
SLGC Valuation Measures
| Enterprise Value | -34296560 USD |
| Trailing P/E | N/A |
| Forward P/E | -3.904762 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.863458 |
| Price/Book (mrq) | 0.86376405 |
| Enterprise Value/Revenue | -0.361 |
| Enterprise Value/EBITDA | 0.206 |
Trading Information
SomaLogic Stock Price History
| Beta (5Y Monthly) | 1.911592 |
| 52-Week Change | -48.31% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.6 USD |
| 52 Week Low | 1.98 USD |
| 50-Day Moving Average | 2.95 USD |
| 200-Day Moving Average | 2.93 USD |
SLGC Share Statistics
| Avg. Volume (3 month) | 1.07M USD |
| Avg. Daily Volume (10-Days) | 1.24M USD |
| Shares Outstanding | 187.94M |
| Float | 151.01M |
| Short Ratio | 11.9 |
| % Held by Insiders | 9.14% |
| % Held by Institutions | 70.23% |
| Shares Short | 8.87M |
| Short % of Float | 5.30% |
| Short % of Shares Outstanding | 4.71% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -146.61% |
| Operating Margin (ttm) | -181.22% |
| Gross Margin | -15.29% |
| EBITDA Margin | -175.36% |
Management Effectiveness
| Return on Assets (ttm) | -16.22% |
| Return on Equity (ttm) | -24.18% |
Income Statement
| Revenue (ttm) | 95.07M USD |
| Revenue Per Share (ttm) | 0.51 USD |
| Quarterly Revenue Growth (yoy) | -11.30% |
| Gross Profit (ttm) | -11271000 USD |
| EBITDA | -166707008 USD |
| Net Income Avi to Common (ttm) | -139380000 USD |
| Diluted EPS (ttm) | -0.72 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 500.57M USD |
| Total Cash Per Share (mrq) | 2.66 USD |
| Total Debt (mrq) | 3.93M USD |
| Total Debt/Equity (mrq) | 0.73 USD |
| Current Ratio (mrq) | 14.073 |
| Book Value Per Share (mrq) | 2.848 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -137799008 USD |
| Levered Free Cash Flow (ttm) | -54368124 USD |
Profile of SomaLogic
| Country | United States |
| State | CO |
| City | Boulder |
| Address | 2945 Wilderness Place |
| ZIP | 80301 |
| Phone | 303 625 9000 |
| Website | https://www.somalogic.com |
| Industry | Health Information Services |
| Sector(s) | Healthcare |
| Full Time Employees | 451 |
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various biological samples for protein biomarker signatures, which are utilized in drug discovery and development. Its SomaScan's biomarker discoveries use in diagnostic applications for various diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal, a laboratory-developed test. It serves pharmaceutical and biotechnology companies, and academic and government research institutions. The company was founded in 1999 and is headquartered in Boulder, Colorado.
Q&A For SomaLogic Stock
What is a current SLGC stock price?
SomaLogic SLGC stock price today per share is 2.1 USD.
How to purchase SomaLogic stock?
You can buy SLGC shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SomaLogic?
The stock symbol or ticker of SomaLogic is SLGC.
Which industry does the SomaLogic company belong to?
The SomaLogic industry is Health Information Services.
How many shares does SomaLogic have in circulation?
The max supply of SomaLogic shares is 188.68M.
What is SomaLogic Price to Earnings Ratio (PE Ratio)?
SomaLogic PE Ratio is 0.00000000 now.
What was SomaLogic earnings per share over the trailing 12 months (TTM)?
SomaLogic EPS is 0 USD over the trailing 12 months.
Which sector does the SomaLogic company belong to?
The SomaLogic sector is Healthcare.
SomaLogic SLGC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
| NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 1647.83 USD — |
-5.17
|
— — | 1610.28 USD — | 1681.06 USD — | — - | — — |
- {{ link.label }} {{link}}